Astellas Pharma Posts 17% Q1 Sales Growth Driven by Xtandi and Padcev
Japan-based Astellas Pharma Inc. (TYO: 4503) reported a 17.1% year-on-year (YOY) increase in global sales...
Finanical Reports
HutchMed’s H1 2022 Oncology Sales Surge 82% on Strong Product Performance
China-based biopharma HutchMed (China) Ltd (NASDAQ: HCM, HKG: 0013) reported strong financial results for the...
Sanofi’s Q2 Earnings Show 8.1% Global Sales Growth, Led by Dupixent and China Expansion
France-based Sanofi (NASDAQ: SNY) reported Q2 2022 global sales of EUR 10.1 billion (USD 10.3...
Merck’s Q2 Sales Surge 31% to USD 14.6B, Led by Keytruda and China Growth
US-based Merck, Sharp & Dohme (MSD, NYSE: MRK) reported Q2 2022 global sales of USD...
Roche Posts 5% H1 Sales Growth, Led by New Drugs and Immunodiagnostics
Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) reported a 5% year-on-year (YOY) increase in...
J&J Q2 Sales Rise 8% but Profits Plunge 23% Amid China COVID Lockdowns
US giant Johnson & Johnson (J&J, NYSE: JNJ) reported Q2 2022 financials, showing 8.0% year-on-year...
Novartis Q2 Results Show 5% Growth, Led by Entresto and Cosentyx
Swiss pharma giant Novartis (NYSE: NVS) reported a 5% year-on-year (YOY) revenue increase in constant...
Alibaba Health’s 2022 Financial Report Shows Revenue Growth, Net Loss
China-based Alibaba Health Information Technology Ltd (HKG: 0241) released its 2022 financial report (for the...